• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Intolerance to cisplatin--a case report.

作者信息

Umbach G E, von Matthiessen H, Wirth G, Goerz G

出版信息

Arch Gynecol. 1985;236(3):183-5. doi: 10.1007/BF02133962.

DOI:10.1007/BF02133962
PMID:4040355
Abstract

A patient who had a systemic reaction to cisplatin chemotherapy had a reaction to subsequent i.c. and i.v. test doses. Notwithstanding she had a more severe systemic reaction during a further course of cisplatin chemotherapy.

摘要

相似文献

1
Intolerance to cisplatin--a case report.
Arch Gynecol. 1985;236(3):183-5. doi: 10.1007/BF02133962.
2
[Severe allergic reaction caused by cisplatin administration].
An Med Interna. 1993 Aug;10(8):415-6.
3
Hypersensitivity and cross-reactivity to cisplatin and analogues.
Cancer Chemother Pharmacol. 1995;35(4):349-51. doi: 10.1007/BF00689458.
4
Case report of anaphylaxis from cisplatin/paclitaxel and a review of their hypersensitivity reaction profiles.
Am J Clin Oncol. 1997 Aug;20(4):373-5. doi: 10.1097/00000421-199708000-00010.
5
Safety of cisplatin after severe hypersensitivity reactions to carboplatin in patients with recurrent ovarian carcinoma.复发性卵巢癌患者对卡铂严重过敏反应后顺铂的安全性
Anticancer Res. 2003 Jul-Aug;23(4):3465-8.
6
Hypersensitivity reaction to cisplatin during chemoradiation therapy for gynecologic malignancy.
Am J Clin Oncol. 2002 Dec;25(6):625-6. doi: 10.1097/00000421-200212000-00020.
7
Immediate hypersensitivity to mannitol: a potential cause of apparent hypersensitivity to cisplatin.
Cancer Treat Rep. 1985 May;69(5):562-3.
8
Hypersensitivity reaction to cancer chemotherapy.
Semin Oncol. 1982 Mar;9(1):5-13.
9
[Investigation of allergic reactions to platinum salts].
Rev Mal Respir. 2006 Nov;23(5 Pt 1):458-62. doi: 10.1016/s0761-8425(06)71817-4.
10
Impact of drug formulation and free platinum/cisplatin ratio on hypersensitivity reactions to cisplatin: formulation matters.
J Clin Pharm Ther. 2015 Feb;40(1):41-7. doi: 10.1111/jcpt.12220. Epub 2014 Oct 27.

本文引用的文献

1
Toxicity of cis-diamminedichloroplatinum II given in a two-hour outpatient regimen of diuresis and hydration.在两小时门诊利尿及水化方案中给予顺二氨二氯铂（II）的毒性反应。
Cancer. 1980 Jan 1;45(1):11-5. doi: 10.1002/1097-0142(19800101)45:1<11::aid-cncr2820450104>3.0.co;2-e.
2
Hypersensitivity reactions to cancer chemotherapeutic agents.对癌症化疗药物的超敏反应。
Ann Intern Med. 1981 Jan;94(1):66-72. doi: 10.7326/0003-4819-94-1-66.
3
[Non allergic skin reactions of drugs (author's transl)].
Derm Beruf Umwelt. 1981;29(3):65-74.
4
Platinum and platinosis. Allergy and histamine release due to some platinum salts.铂与铂中毒。某些铂盐引起的过敏及组胺释放。
Arch Environ Health. 1969 Nov;19(5):685-91. doi: 10.1080/00039896.1969.10666910.
5
High dose cis-platinum diammine dichloride: amelioration of renal toxicity by mannitol diuresis.高剂量顺铂二氯二氨络铂：通过甘露醇利尿改善肾毒性。
Cancer. 1977 Apr;39(4):1372-81. doi: 10.1002/1097-0142(197704)39:4<1372::aid-cncr2820390404>3.0.co;2-j.
6
Treatment of genitourinary tumours with cis-dichlorodiammineplatinum(II): experience in 250 patients.
Cancer Treat Rep. 1979 Sep-Oct;63(9-10):1579-84.
7
Toxic effects of cis-dichlorodiammineplatinum(II) in man.顺二氯二氨合铂（II）对人体的毒性作用。
Cancer Treat Rep. 1979 Sep-Oct;63(9-10):1527-31.
8
Phase II study of cis-dichlorodiammineplatinum(II) in childhood osteosarcoma: Children's Cancer Study Group Report.顺二氯二氨铂（II）用于儿童骨肉瘤的II期研究：儿童癌症研究组报告
Cancer Treat Rep. 1979 Sep-Oct;63(9-10):1621-7.
9
Chemotherapy for testicular cancer: current status of the National Cancer Institute Combined Modality Trial.睾丸癌的化疗：国立癌症研究所综合治疗试验的现状
Cancer Treat Rep. 1979 Sep-Oct;63(9-10):1687-92.
10
Successful re-treatment with cis-dichlorodiammineplatinum(II) after apparent allergic reactions.
Cancer Treat Rep. 1979 Feb;63(2):219-21.